11/12
06:53 am
phvs
Pharvaris to Participate in the Guggenheim Healthcare Innovation Conference [Yahoo! Finance]
Low
Report
Pharvaris to Participate in the Guggenheim Healthcare Innovation Conference [Yahoo! Finance]
11/12
06:50 am
phvs
Pharvaris to Participate in the Guggenheim Healthcare Innovation Conference
Medium
Report
Pharvaris to Participate in the Guggenheim Healthcare Innovation Conference
10/24
08:00 am
phvs
Pharvaris Presents Clinical and Non-Clinical Data Supporting HAE Development Program at the 2024 ACAAI Annual Scientific Meeting
Medium
Report
Pharvaris Presents Clinical and Non-Clinical Data Supporting HAE Development Program at the 2024 ACAAI Annual Scientific Meeting
10/16
06:50 am
phvs
Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at Upcoming Scientific Meetings
Medium
Report
Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at Upcoming Scientific Meetings
10/15
06:55 am
phvs
Pharvaris to Host Virtual Investor Event on October 23, 2024 [Yahoo! Finance]
Low
Report
Pharvaris to Host Virtual Investor Event on October 23, 2024 [Yahoo! Finance]
10/15
06:50 am
phvs
Pharvaris to Host Virtual Investor Event on October 23, 2024
Low
Report
Pharvaris to Host Virtual Investor Event on October 23, 2024
10/3
06:55 am
phvs
Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at the 2024 HAEi Global Leadership Workshop [Yahoo! Finance]
Low
Report
Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at the 2024 HAEi Global Leadership Workshop [Yahoo! Finance]
10/3
06:50 am
phvs
Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at the 2024 HAEi Global Leadership Workshop
Low
Report
Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at the 2024 HAEi Global Leadership Workshop
9/19
09:09 am
phvs
Pharvaris (NASDAQ:PHVS) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]
Medium
Report
Pharvaris (NASDAQ:PHVS) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]
9/6
09:01 am
phvs
Pharvaris (NASDAQ: PHVS) had its price target raised by analysts at Oppenheimer Holdings Inc. from $38.00 to $42.00. They now have an "outperform" rating on the stock.
Low
Report
Pharvaris (NASDAQ: PHVS) had its price target raised by analysts at Oppenheimer Holdings Inc. from $38.00 to $42.00. They now have an "outperform" rating on the stock.
9/5
07:03 am
phvs
Pharvaris Presents Data at the Bradykinin Symposium 2024 [Yahoo! Finance]
High
Report
Pharvaris Presents Data at the Bradykinin Symposium 2024 [Yahoo! Finance]
9/5
07:03 am
phvs
Pharvaris Provides Business Update and Expands Development Program for Deucrictibant [Yahoo! Finance]
High
Report
Pharvaris Provides Business Update and Expands Development Program for Deucrictibant [Yahoo! Finance]
9/5
07:03 am
phvs
Pharvaris Presents Deucrictibant Long-Term Extension Data for Both the Prophylactic and On-Demand Treatment of HAE at the Bradykinin Symposium 2024 [Yahoo! Finance]
High
Report
Pharvaris Presents Deucrictibant Long-Term Extension Data for Both the Prophylactic and On-Demand Treatment of HAE at the Bradykinin Symposium 2024 [Yahoo! Finance]
9/5
06:50 am
phvs
Pharvaris Provides Business Update and Expands Development Program for Deucrictibant
High
Report
Pharvaris Provides Business Update and Expands Development Program for Deucrictibant
9/5
06:49 am
phvs
Pharvaris Presents Deucrictibant Long-Term Extension Data for Both the Prophylactic and On-Demand Treatment of HAE at the Bradykinin Symposium 2024
High
Report
Pharvaris Presents Deucrictibant Long-Term Extension Data for Both the Prophylactic and On-Demand Treatment of HAE at the Bradykinin Symposium 2024
9/5
06:48 am
phvs
Pharvaris Presents Data at the Bradykinin Symposium 2024
High
Report
Pharvaris Presents Data at the Bradykinin Symposium 2024
8/28
06:50 am
phvs
Deucrictibant Clinical, Real-World, Nonclinical, and Discovery Data to be Presented at the Bradykinin Symposium
Low
Report
Deucrictibant Clinical, Real-World, Nonclinical, and Discovery Data to be Presented at the Bradykinin Symposium